Kira Radinsky

Kira Radinsky is co-founder of mana, which uses AI and data to design lipid nanoparticles for targeted delivery of nucleic-acid medicines. Her work builds on earlier research using machine learning and text analysis to forecast real-world events, including disease outbreaks.

Career

Cosigned byLoading...

CosignedSign in to view

Elsewhere

mana

Until Present

Co-Founder

Products & media

crafted.fm

AI and the Future of Medicine

An interview on Mana.bio’s AI approach to drug discovery and targeted drug delivery, alongside Radinsky’s work applying prediction systems in healthcare.

Media appearance

labtostartup.com

Designing the Future of Drug Delivery: How AI is Solving RNA's Biggest Challenge

A conversation about using data, machine learning, and screening to design lipid nanoparticles for targeted delivery of RNA medicines.

Media appearance

gradientflow.com

Forecasting events, from disease outbreaks to sales to cancer research

An interview about Radinsky’s machine-learning and language-analysis methods for forecasting events and their potential applications in medicine.

Writing

Profile name

Company name

Company name

Profile name

Company name

Company name

Profile name

Company name

Company name

Profile name

Company name

Company name

Profile name

Company name

Company name

Kira Radinsky

mana

Products & media

AI and the Future of Medicine

Designing the Future of Drug Delivery: How AI is Solving RNA's Biggest Challenge

Forecasting events, from disease outbreaks to sales to cancer research

Curated Lists

List Inclusions